Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)
Teva reaches $100M settlement with Rhode Island for decade of anti-narcotic drugs and $21M cash
Kåre Schultz, the top dog at Teva Pharmaceuticals, said last month on a Q4 call that the pharma giant was confident it could reach a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
